Companies / Santa Cruz Biotechnology / Bcl-6 (D-8) AC
Santa Cruz Biotechnology

Bcl-6 (D-8) AC | Santa Cruz Biotechnology

mouse monoclonal IgG3; Bcl-6 Antibody (D-8) is an IgG3 κ mouse monoclonal Bcl-6 antibody (also designated BCL6 transcription repressor antibody) that detects the Bcl-6 protein of mouse, rat and human origin by WB, IP, IF and IHC(P). Bcl-6 Antibody (D-8) is available as both the non-conjugated anti-Bcl-6 antibody form, as well as multiple conjugated forms of anti-Bcl-6 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. Bcl-6, a transcriptional repressor, binds Stat recognition-like DNA elements and influences germinal center development and Th1/Th2 differentiation. Bcl-6 negatively regulates NFkB expression, thereby inhibiting NFkB-mediated cellular functions. HDAC- and silent information regulator (SIR)-2-dependent acet-ylation of Bcl-6 causes downregulation of activity by inhibiting the ability of Bcl-6 to recruit complexes containing histone deacetylases (HDACs). Bcl-6 is frequently deregulated in non-Hodgkin's B cell lymphomas. The human BCL6 gene has been shown to encode a protein of 706 amino acids.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.